nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Anaphylactoid reaction—Didanosine—acquired immunodeficiency syndrome	0.0199	0.0199	CcSEcCtD
Metaxalone—Abdominal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.0175	0.0175	CcSEcCtD
Metaxalone—Haemolytic anaemia—Zidovudine—acquired immunodeficiency syndrome	0.0161	0.0161	CcSEcCtD
Metaxalone—Haemolytic anaemia—Indinavir—acquired immunodeficiency syndrome	0.0149	0.0149	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Indinavir—acquired immunodeficiency syndrome	0.0139	0.0139	CcSEcCtD
Metaxalone—Irritability—Zidovudine—acquired immunodeficiency syndrome	0.0138	0.0138	CcSEcCtD
Metaxalone—Abdominal discomfort—Abacavir—acquired immunodeficiency syndrome	0.0136	0.0136	CcSEcCtD
Metaxalone—Haemolytic anaemia—Delavirdine—acquired immunodeficiency syndrome	0.0135	0.0135	CcSEcCtD
Metaxalone—Jaundice—Nevirapine—acquired immunodeficiency syndrome	0.013	0.013	CcSEcCtD
Metaxalone—Jaundice—Nelfinavir—acquired immunodeficiency syndrome	0.0126	0.0126	CcSEcCtD
Metaxalone—Jaundice—Stavudine—acquired immunodeficiency syndrome	0.0125	0.0125	CcSEcCtD
Metaxalone—Haemolytic anaemia—Saquinavir—acquired immunodeficiency syndrome	0.012	0.012	CcSEcCtD
Metaxalone—Jaundice—Zidovudine—acquired immunodeficiency syndrome	0.0109	0.0109	CcSEcCtD
Metaxalone—Leukopenia—Didanosine—acquired immunodeficiency syndrome	0.0104	0.0104	CcSEcCtD
Metaxalone—Irritability—Saquinavir—acquired immunodeficiency syndrome	0.0104	0.0104	CcSEcCtD
Metaxalone—Jaundice—Indinavir—acquired immunodeficiency syndrome	0.0101	0.0101	CcSEcCtD
Metaxalone—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.00982	0.00982	CcSEcCtD
Metaxalone—Jaundice—Efavirenz—acquired immunodeficiency syndrome	0.00958	0.00958	CcSEcCtD
Metaxalone—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.00945	0.00945	CcSEcCtD
Metaxalone—Jaundice—Delavirdine—acquired immunodeficiency syndrome	0.00916	0.00916	CcSEcCtD
Metaxalone—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.00902	0.00902	CcSEcCtD
Metaxalone—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.009	0.009	CcSEcCtD
Metaxalone—Abdominal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00899	0.00899	CcSEcCtD
Metaxalone—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.00886	0.00886	CcSEcCtD
Metaxalone—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00858	0.00858	CcSEcCtD
Metaxalone—Tension—Zidovudine—acquired immunodeficiency syndrome	0.00857	0.00857	CcSEcCtD
Metaxalone—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.0085	0.0085	CcSEcCtD
Metaxalone—Nervousness—Zidovudine—acquired immunodeficiency syndrome	0.00849	0.00849	CcSEcCtD
Metaxalone—Jaundice—Ritonavir—acquired immunodeficiency syndrome	0.00847	0.00847	CcSEcCtD
Metaxalone—Jaundice—Saquinavir—acquired immunodeficiency syndrome	0.00815	0.00815	CcSEcCtD
Metaxalone—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00808	0.00808	CcSEcCtD
Metaxalone—Tension—Indinavir—acquired immunodeficiency syndrome	0.00797	0.00797	CcSEcCtD
Metaxalone—Nervousness—Indinavir—acquired immunodeficiency syndrome	0.00789	0.00789	CcSEcCtD
Metaxalone—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.00782	0.00782	CcSEcCtD
Metaxalone—Jaundice—Lamivudine—acquired immunodeficiency syndrome	0.00778	0.00778	CcSEcCtD
Metaxalone—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00755	0.00755	CcSEcCtD
Metaxalone—Tension—Efavirenz—acquired immunodeficiency syndrome	0.00753	0.00753	CcSEcCtD
Metaxalone—Nervousness—Efavirenz—acquired immunodeficiency syndrome	0.00746	0.00746	CcSEcCtD
Metaxalone—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00733	0.00733	CcSEcCtD
Metaxalone—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00732	0.00732	CcSEcCtD
Metaxalone—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.00729	0.00729	CcSEcCtD
Metaxalone—Tension—Delavirdine—acquired immunodeficiency syndrome	0.00721	0.00721	CcSEcCtD
Metaxalone—Nervousness—Delavirdine—acquired immunodeficiency syndrome	0.00713	0.00713	CcSEcCtD
Metaxalone—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00713	0.00713	CcSEcCtD
Metaxalone—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00696	0.00696	CcSEcCtD
Metaxalone—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00669	0.00669	CcSEcCtD
Metaxalone—Tension—Ritonavir—acquired immunodeficiency syndrome	0.00667	0.00667	CcSEcCtD
Metaxalone—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00663	0.00663	CcSEcCtD
Metaxalone—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.0066	0.0066	CcSEcCtD
Metaxalone—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00659	0.00659	CcSEcCtD
Metaxalone—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00657	0.00657	CcSEcCtD
Metaxalone—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00654	0.00654	CcSEcCtD
Metaxalone—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00653	0.00653	CcSEcCtD
Metaxalone—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00649	0.00649	CcSEcCtD
Metaxalone—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00634	0.00634	CcSEcCtD
Metaxalone—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00626	0.00626	CcSEcCtD
Metaxalone—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00616	0.00616	CcSEcCtD
Metaxalone—Tension—Lamivudine—acquired immunodeficiency syndrome	0.00612	0.00612	CcSEcCtD
Metaxalone—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00608	0.00608	CcSEcCtD
Metaxalone—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00606	0.00606	CcSEcCtD
Metaxalone—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.00606	0.00606	CcSEcCtD
Metaxalone—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00604	0.00604	CcSEcCtD
Metaxalone—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00601	0.00601	CcSEcCtD
Metaxalone—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00601	0.00601	CcSEcCtD
Metaxalone—Rash—Didanosine—acquired immunodeficiency syndrome	0.00596	0.00596	CcSEcCtD
Metaxalone—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00595	0.00595	CcSEcCtD
Metaxalone—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00595	0.00595	CcSEcCtD
Metaxalone—Headache—Didanosine—acquired immunodeficiency syndrome	0.00592	0.00592	CcSEcCtD
Metaxalone—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00589	0.00589	CcSEcCtD
Metaxalone—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00585	0.00585	CcSEcCtD
Metaxalone—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00582	0.00582	CcSEcCtD
Metaxalone—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.0058	0.0058	CcSEcCtD
Metaxalone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00572	0.00572	CcSEcCtD
Metaxalone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00561	0.00561	CcSEcCtD
Metaxalone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00558	0.00558	CcSEcCtD
Metaxalone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00557	0.00557	CcSEcCtD
Metaxalone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00544	0.00544	CcSEcCtD
Metaxalone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00542	0.00542	CcSEcCtD
Metaxalone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.0054	0.0054	CcSEcCtD
Metaxalone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00536	0.00536	CcSEcCtD
Metaxalone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00535	0.00535	CcSEcCtD
Metaxalone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00534	0.00534	CcSEcCtD
Metaxalone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00533	0.00533	CcSEcCtD
Metaxalone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00532	0.00532	CcSEcCtD
Metaxalone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00523	0.00523	CcSEcCtD
Metaxalone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00522	0.00522	CcSEcCtD
Metaxalone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00519	0.00519	CcSEcCtD
Metaxalone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00518	0.00518	CcSEcCtD
Metaxalone—Rash—Stavudine—acquired immunodeficiency syndrome	0.00517	0.00517	CcSEcCtD
Metaxalone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00517	0.00517	CcSEcCtD
Metaxalone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00515	0.00515	CcSEcCtD
Metaxalone—Headache—Stavudine—acquired immunodeficiency syndrome	0.00514	0.00514	CcSEcCtD
Metaxalone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00514	0.00514	CcSEcCtD
Metaxalone—Rash—Abacavir—acquired immunodeficiency syndrome	0.0051	0.0051	CcSEcCtD
Metaxalone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00509	0.00509	CcSEcCtD
Metaxalone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00509	0.00509	CcSEcCtD
Metaxalone—Headache—Abacavir—acquired immunodeficiency syndrome	0.00506	0.00506	CcSEcCtD
Metaxalone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00505	0.00505	CcSEcCtD
Metaxalone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00504	0.00504	CcSEcCtD
Metaxalone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00493	0.00493	CcSEcCtD
Metaxalone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00489	0.00489	CcSEcCtD
Metaxalone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00489	0.00489	CcSEcCtD
Metaxalone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00487	0.00487	CcSEcCtD
Metaxalone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.0048	0.0048	CcSEcCtD
Metaxalone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00474	0.00474	CcSEcCtD
Metaxalone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00471	0.00471	CcSEcCtD
Metaxalone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00469	0.00469	CcSEcCtD
Metaxalone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00462	0.00462	CcSEcCtD
Metaxalone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00453	0.00453	CcSEcCtD
Metaxalone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00452	0.00452	CcSEcCtD
Metaxalone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0045	0.0045	CcSEcCtD
Metaxalone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00449	0.00449	CcSEcCtD
Metaxalone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00447	0.00447	CcSEcCtD
Metaxalone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00443	0.00443	CcSEcCtD
Metaxalone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00442	0.00442	CcSEcCtD
Metaxalone—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00438	0.00438	CcSEcCtD
Metaxalone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00424	0.00424	CcSEcCtD
Metaxalone—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00424	0.00424	CcSEcCtD
Metaxalone—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00422	0.00422	CcSEcCtD
Metaxalone—Rash—Indinavir—acquired immunodeficiency syndrome	0.00418	0.00418	CcSEcCtD
Metaxalone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00418	0.00418	CcSEcCtD
Metaxalone—Headache—Indinavir—acquired immunodeficiency syndrome	0.00415	0.00415	CcSEcCtD
Metaxalone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00414	0.00414	CcSEcCtD
Metaxalone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00408	0.00408	CcSEcCtD
Metaxalone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00398	0.00398	CcSEcCtD
Metaxalone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00396	0.00396	CcSEcCtD
Metaxalone—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00395	0.00395	CcSEcCtD
Metaxalone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00395	0.00395	CcSEcCtD
Metaxalone—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00394	0.00394	CcSEcCtD
Metaxalone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00393	0.00393	CcSEcCtD
Metaxalone—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00392	0.00392	CcSEcCtD
Metaxalone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00392	0.00392	CcSEcCtD
Metaxalone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00381	0.00381	CcSEcCtD
Metaxalone—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00378	0.00378	CcSEcCtD
Metaxalone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00378	0.00378	CcSEcCtD
Metaxalone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00377	0.00377	CcSEcCtD
Metaxalone—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00376	0.00376	CcSEcCtD
Metaxalone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00375	0.00375	CcSEcCtD
Metaxalone—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00372	0.00372	CcSEcCtD
Metaxalone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00367	0.00367	CcSEcCtD
Metaxalone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.0036	0.0036	CcSEcCtD
Metaxalone—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00356	0.00356	CcSEcCtD
Metaxalone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00353	0.00353	CcSEcCtD
Metaxalone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00352	0.00352	CcSEcCtD
Metaxalone—Rash—Ritonavir—acquired immunodeficiency syndrome	0.0035	0.0035	CcSEcCtD
Metaxalone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00349	0.00349	CcSEcCtD
Metaxalone—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00347	0.00347	CcSEcCtD
Metaxalone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00339	0.00339	CcSEcCtD
Metaxalone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00337	0.00337	CcSEcCtD
Metaxalone—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00336	0.00336	CcSEcCtD
Metaxalone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00336	0.00336	CcSEcCtD
Metaxalone—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00334	0.00334	CcSEcCtD
Metaxalone—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00329	0.00329	CcSEcCtD
Metaxalone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00324	0.00324	CcSEcCtD
Metaxalone—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00321	0.00321	CcSEcCtD
Metaxalone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00321	0.00321	CcSEcCtD
Metaxalone—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00319	0.00319	CcSEcCtD
Metaxalone—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.00317	CcSEcCtD
Metaxalone—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00302	0.00302	CcSEcCtD
